Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Coral Laboratories has informed BSE that its Board of Directors will meet on Friday, November 14, 2025, at the registered office in Ghatkopar West, Mumbai. The main agenda is to consider and adopt the unaudited standalone financial results along with the statement of assets & liabilities and cash flow statement for the quarter and half year ended September 30, 2025, along with the limited review report. The trading window has been closed from October 1, 2025, until November 16, 2025 (48 hours after the board meeting), in line with insider trading norms. No specific financial numbers or outcomes have been disclosed in this notice — only the meeting schedule.
This is a routine pre-results intimation with no direct impact on the stock. Investors should watch for the actual Q2/H1 FY26 results on or after November 14, 2025, which could move the stock based on earnings quality. Until then, the closed trading window restricts insider trading.